Inhibitor Therapeutics, Inc. ROE

The ROE as of November 2026 (TTM) for Inhibitor Therapeutics, Inc. (INTI) is 227.11%

According to Inhibitor Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 227.11%. This represents a change of -104.44% compared to the average of -5116.53% of the last 4 quarters.

Inhibitor Therapeutics, Inc. (INTI) Historical ROE (quarterly & annually)

How has INTI ROE performed in the past?

The mean historical ROE of Inhibitor Therapeutics, Inc. over the last ten years is -1690.35%. The current 227.11% ROE has changed -113.44% with respect to the historical average. Over the past ten years (40 quarters), INTI's ROE was at its highest in in the December 2022 quarter at 148.98%. The ROE was at its lowest in in the September 2025 quarter at -20625.08%.

Inhibitor Therapeutics, Inc. (INTI) ROE by Quarter and Year

Discovering the peaks and valleys of Inhibitor Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inhibitor Therapeutics, Inc. (INTI) Average ROE

How has INTI ROE performed in the past?

The current ROE of Inhibitor Therapeutics, Inc. (INTI) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Inhibitor Therapeutics, Inc. (INTI) ROE vs. Peers

How is INTI’s ROE compared to its peers?

Inhibitor Therapeutics, Inc.’s ROE is greater than Allarity Therapeutics, Inc. (-152.77%), greater than Actuate Therapeutics Inc (-346.18%), less than Oncolytics Biotech Inc. (1.02%), less than Oncotelic Therapeutics, Inc. (123.80%), greater than Curis, Inc. (-1035.26%), greater than ORIC Pharmaceuticals, Inc. (-35.35%), greater than Kazia Therapeutics Ltd ADR (-116.86%), greater than ArriVent BioPharma, Inc. (-50.26%), greater than Cardiff Oncology, Inc. (-103.08%), greater than Atossa Therapeutics, Inc. (-102.99%),

Build a custom stock screener for Inhibitor Therapeutics, Inc. (INTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inhibitor Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inhibitor Therapeutics, Inc. (INTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inhibitor Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.